National Cancer Institute; Amended Notice of Meeting, 8268 [2012-3430]
Download as PDF
<![CDATA[
8268
Federal Register / Vol. 77, No. 30 / Tuesday, February 14, 2012 / Notices
Dated: February 7, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Notice is hereby given of a change in
the meeting of the National Cancer
Advisory Board, February 27, 2012, 6:30
PM to February 29, 2012, 12:00 PM,
National Institutes of Health, Building
31, 31 Center Drive, 10, Bethesda, MD
20892 which was published in the
Federal Register on January 18, 2012, 77
FR 2557–2558.
This notice is being amended to add
the NCAB Subcommittee on Clinical
Investigations meeting on February 27,
2012, 5 p.m. to 6:30 p.m. at the Hyatt
Regency Bethesda Hotel, One Metro
Center, Bethesda, MD 20814. The NCAB
Ad Hoc Subcommittee on Global Cancer
Research will still convene on February
27, 2012, 6:30 p.m. to 8 p.m. The
National Cancer Advisory Board
meeting has been changed to February
28, 2012 from 9 a.m. to 5 p.m., instead
of February 28–29, 2012. The meeting is
partially closed to the public.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trial SEP.
Date: March 2, 2012.
Time: 6 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 700 F Street NW.,
Washington, DC 20001.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, 301–435–6033,
Rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; K99R00 Conflict Review.
Date: March 6, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 F Street NW.,
Washington, DC 20037.
Contact Person: JoAnn McConnell, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, 301–496–5324,
McConnej@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; NIDCR U01 application
Review.
Date: March 7, 2012.
Time: 12:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jayalakshmi Raman, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, One Democracy Plaza
Room 670, Bethesda, MD 20892–4878, 301–
594–2904, ramanj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: February 10, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: February 7, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–3430 Filed 2–13–12; 8:45 a.m.]
[FR Doc. 2012–3438 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke Notice of Closed
Meetings
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2012–3434 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Cancer Institute; Amended
Notice of Meeting
VerDate Mar<15>2010
21:57 Feb 13, 2012
Jkt 226001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Dated: February 8, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–3449 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: March 8, 2012.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fisher’s Lane, Room 4076,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Camilla E. Day, Ph.D.,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 77, Number 30 (Tuesday, February 14, 2012)]
[Notices]
[Page 8268]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3430]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Advisory Board, February 27, 2012, 6:30 PM to February 29, 2012,
12:00 PM, National Institutes of Health, Building 31, 31 Center Drive,
10, Bethesda, MD 20892 which was published in the Federal Register on
January 18, 2012, 77 FR 2557-2558.
This notice is being amended to add the NCAB Subcommittee on
Clinical Investigations meeting on February 27, 2012, 5 p.m. to 6:30
p.m. at the Hyatt Regency Bethesda Hotel, One Metro Center, Bethesda,
MD 20814. The NCAB Ad Hoc Subcommittee on Global Cancer Research will
still convene on February 27, 2012, 6:30 p.m. to 8 p.m. The National
Cancer Advisory Board meeting has been changed to February 28, 2012
from 9 a.m. to 5 p.m., instead of February 28-29, 2012. The meeting is
partially closed to the public.
Dated: February 10, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-3430 Filed 2-13-12; 8:45 a.m.]
BILLING CODE 4140-01-P
